M.L. LABORATORIES PLC
Patent Owner
Stats
- 8 US PATENTS IN FORCE
- 0 US APPLICATIONS PENDING
- Oct 12, 2010 most recent publication
Details
- 8 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 303 Total Citation Count
- Jan 25, 1991 Earliest Filing
- 38 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
- No Recent Publications to Display
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
7812148 Vectors comprising CpG islands without position effect varigation and having increased expressionApr 05, 02Oct 12, 10[C07H, A61K, A01N]
5744456 Methods for obtaining production of a gene product in a host cell in vivo or in vitro using a DNA molecule for integration site independent gene expressionJun 07, 95Apr 28, 98[A61K, C12N]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2005/0080,045 Composition comprising dextrinsulfate for the treatment of sexual transmitted diseases (std)AbandonedJun 23, 04Apr 14, 05[A61K]
6797494 Self-replicating episomal expression vectors conferring tissue-specific gene expressionExpiredFeb 09, 99Sep 28, 04[C12P, C12N]
2004/0161,817 Compositions and methods for high-level, large-scale production of recombinant proteinsAbandonedJun 04, 02Aug 19, 04[C12P, C12N]
6689764 Treatment of angiogenesis dependent conditions with dextrin sulphateExpiredMay 31, 02Feb 10, 04[A61K, A61P]
2003/0158,137 Gene directed enzyme prodrug theraphy (gdept) for cell ablationAbandonedMar 20, 03Aug 21, 03[A61K]
2003/0100,496 Compositions and methods for highly efficient transfectionAbandonedAug 15, 02May 29, 03[A61K, C07K]
2002/0123,037 Selection Procedure Using Prodrug/Enzyme SystemAbandonedNov 06, 01Sep 05, 02[C07H, C12Q, C12N, G01N]
Top Inventors for This Owner
Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.